These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


623 related items for PubMed ID: 10930003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 3. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of thyrotropin-secreting pituitary adenomas.
    McCutcheon IE, Weintraub BD, Oldfield EH.
    J Neurosurg; 1990 Nov; 73(5):674-83. PubMed ID: 2213157
    [Abstract] [Full Text] [Related]

  • 5. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER.
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
    Ceylan S, Koc K, Anik I.
    J Neurosurg; 2010 Jan; 112(1):99-107. PubMed ID: 19480546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 15. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
    Kim SH, Ku CR, Na M, Yoo J, Kim W, Jung IH, Kim KW, Moon JH, Kim D, Lee EJ, Kim SH, Kim EH.
    J Neurosurg; 2021 Mar 01; 134(3):794-800. PubMed ID: 32168476
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus.
    Kitano M, Taneda M, Shimono T, Nakao Y.
    J Neurosurg; 2008 Jan 01; 108(1):26-36. PubMed ID: 18173307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.